ADAKVEO 10 mg/mL
crizanlizumab · INJECTION · Novartis Pharmaceuticals Corporation
No Recall History
Plain English
ADAKVEO is a injection containing crizanlizumab at 10 mg/mL, taken intravenous. Manufactured by Novartis Pharmaceuticals Corporation.
Key Facts
- Brand Name
- ADAKVEO
- Generic Name
- crizanlizumab
- NDC Code (Product)
0078-0883- Manufacturer
- Novartis Pharmaceuticals Corporation
- Strength
- 10 mg/mL
- Dosage Form
- INJECTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA761128
- Drug Class
- Selectin Blocker [EPC]
- Marketing Start
- 11/15/2019
Recall History
No Recall HistoryFrequently Asked Questions
What is ADAKVEO used for?
ADAKVEO contains crizanlizumab. It is a injection taken intravenous. Consult your doctor for specific uses.
Is ADAKVEO a controlled substance?
ADAKVEO is not classified as a controlled substance by the DEA.
What is the generic name for ADAKVEO?
The generic name for ADAKVEO is crizanlizumab. There are no other listed brand versions of crizanlizumab.
What is the NDC code for ADAKVEO 10 mg/mL?
The NDC (National Drug Code) for ADAKVEO 10 mg/mL is 0078-0883, listed by Novartis Pharmaceuticals Corporation.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)